Scientists have now developed a machine learning method that supports the antibody optimization phase, helping to develop more effective antibody drugs
We’ve updated our Privacy Policy to make it clearer how we use your personal data.
Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.